Selectis Health extends $1.775M notes to Feb 2026, interest rate raised to 13%

SELECTIS HEALTH, INC.

Maturity extended to Feb 28, 2026 or earlier upon Qualified Transaction; 30-day extensions possible with 0.5% fee.
Interest rate increased from 11% to 13% per annum effective Jan 1, 2026.
Warrants extended to Dec 31, 2027; exercise price unchanged at $2.25 per share.
Kent Lund and Lance Baller appointed to Board of Directors effective Jan 1, 2026.
Solicitation fee of $9,000 paid to GVC Capital LLC in connection with the amendment.

item 2.03 item 3.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.95

SELECTIS HEALTH, INC. issued convertible note.

Security: convertible note

Exact text from the filing

Effective December 31, 2025, the Company entered into a Third Amended and Restated Allonge and Modification Agreement (the “Third Allonge”) with the holders of more than a majority in interest in the Company’s 2018 11% Senior Secured Promissory Notes (the “Notes”).

View on SEC.gov

32 equity issuances filed in the last 30 days. Browse all equity issuances →

SELECTIS HEALTH, INC. filing history →

Source: SEC EDGAR

accession 0001493152-25-029572

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.